Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01848756
Title Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Esanex Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Healthcare Scottsdale Arizona 85258 United States Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field